Publication:
Use of multikinase inhibitors/lenvatinib concomitant with locoregional therapies for the treatment of radioiodine-refractory differentiated thyroid cancer.

Simple item page
dc.contributor.authorBerciano-Guerrero, Miguel-Ángel
dc.date.accessioned2023-05-03T14:06:59Z
dc.date.available2023-05-03T14:06:59Z
dc.date.issued2022
dc.description.abstractLocoregional recurrence of differentiated thyroid cancer (DTC) occurs in 20% of thyroid cancer patients. Currently, there are many strategies for management of locoregional recurrence of DTC that lead to local control of the disease. The introduction of lenvatinib into the therapeutic armamentarium provides a new option for the treatment of radioiodine-refractory DTC (RR-DTC). However, results for simultaneous treatment with lenvatinib and locoregional therapies are unknown in patients with RR-DTC. This paper reviews the current status of this approach and gives recommendations on the management of lenvatinib during concomitant locoregional procedures.
dc.identifier.doi10.1002/cam4.5108
dc.identifier.essn2045-7634
dc.identifier.pmcPMC9537059
dc.identifier.pmid36202609
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537059/pdf
dc.identifier.unpaywallURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537059
dc.identifier.urihttp://hdl.handle.net/10668/21285
dc.issue.numberSuppl 1
dc.journal.titleCancer medicine
dc.journal.titleabbreviationCancer Med
dc.language.isoen
dc.organizationHospital Universitario Virgen de la Victoria
dc.organizationHospital Universitario Virgen de la Victoria
dc.page.number40-46
dc.pubmedtypeJournal Article
dc.pubmedtypeReview
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.rights.accessRightsopen access
dc.subjectenolization
dc.subjectlenvatinib
dc.subjectradiotherapy
dc.subjectsurgery
dc.subject.meshAdenocarcinoma
dc.subject.meshAntineoplastic Agents
dc.subject.meshHumans
dc.subject.meshIodine Radioisotopes
dc.subject.meshNeoplasm Recurrence, Local
dc.subject.meshPhenylurea Compounds
dc.subject.meshProtein Kinase Inhibitors
dc.subject.meshQuinolines
dc.subject.meshThyroid Neoplasms
dc.titleUse of multikinase inhibitors/lenvatinib concomitant with locoregional therapies for the treatment of radioiodine-refractory differentiated thyroid cancer.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number11 Suppl 1
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
PMC9537059.pdf
Size:
458.28 KB
Format:
Adobe Portable Document Format
Download

Collections

SAS - Hospital Universitario Virgen de la Victoria

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía